Reveal LINQ vs Vivid T8

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Reveal LINQ

by Medtronic

Vivid T8

by GE HealthCare

AI Verdict

The Medtronic Reveal LINQ is an implantable cardiac monitor for long-term ECG recording and AI-powered arrhythmia detection, ideal for diagnosing infrequent symptoms over extended periods. In contrast, the GE HealthCare Vivid T8 is a cardiovascular ultrasound system that uses AI to enhance real-time imaging and workflow for immediate structural and functional assessment. While both leverage AI in cardiology, they serve distinct diagnostic purposes, making them complementary rather than direct competitors.

Choose Reveal LINQ if…

Choose Reveal LINQ if you need long-term, continuous cardiac monitoring for patients experiencing infrequent, transient symptoms like dizziness, palpitations, or syncope, or those at high risk for cardiac arrhythmias such as atrial fibrillation or cryptogenic stroke. Its implantable nature and up to three-year battery life ensure comprehensive data capture for elusive events that short-term monitors might miss.

View Reveal LINQ →

Choose Vivid T8 if…

Choose GE Vivid T8 if your practice requires a versatile, cost-effective cardiovascular ultrasound system for both advanced cardiac imaging and shared services. It is ideal for clinics needing robust quantitative tools, AI-based workflow efficiency, and the flexibility to perform a wide range of cardiovascular and general imaging exams.

View Vivid T8 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Reveal LINQ	Vivid T8
Pricing	Contact vendor for pricing	Contact vendor
Deployment	Implantable medical device with a bedside patient monitor (MyCareLink™) for data transmission and a mobile app (Reveal LINQ™ Mobile Manager) for clinicians.	On-premise (console-based medical device)
BAA Available	Unknown	Yes AI-estimated
FDA Status	Yes AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Reveal LINQ

Reveal LINQ offers a minimally invasive, simplified insertion procedure that takes only minutes and can be done in-office, leading to quick discharge for the patient. Its wireless data transmission and mobile app for clinicians also enhance ease of use for both patients and healthcare providers.

Clinical Value

Reveal LINQ

Reveal LINQ provides continuous ECG monitoring for up to three years, offering superior detection of atrial fibrillation and other arrhythmias compared to standard monitoring methods, which is crucial for diagnosing cryptogenic stroke and unexplained syncope. Its AccuRhythmu2122 AI algorithms are designed to reduce false alerts and improve diagnostic accuracy, leading to more actionable data and timely therapeutic interventions.

Pricing & Value

Vivid T8

While both tools require contacting the vendor for new pricing, the GE Vivid T8 has publicly available pricing for refurbished units starting at $22,800 and includes three years of service coverage. Reveal LINQ's pricing is not publicly disclosed, making it difficult to assess its upfront cost-effectiveness, although studies suggest it can lead to cost savings by reducing the need for more resource-intensive procedures.

Enterprise Readiness

Tie

Both devices are FDA cleared and emphasize HIPAA compliance for patient data. Reveal LINQ integrates with the CareLinku2122 network and offers a mobile app for clinicians, suggesting robust data management. The Vivid T8, particularly the Ultra Edition, includes AI-based tools for workflow efficiency and DICOM/EchoPAC compatibility for image analysis and sharing, indicating strong integration capabilities within a hospital setting.

Innovation

Reveal LINQ

Reveal LINQ is highlighted as the world's smallest insertable cardiac monitor, a significant innovation in patient comfort and ease of insertion. Its continuous, long-term monitoring with AI-powered AccuRhythmu2122 algorithms for enhanced AF detection and reduced false positives represents a cutting-edge approach to cardiac diagnostics.

Support & Docs

Tie

Both Medtronic and GE HealthCare are major medical device manufacturers with established reputations for providing support and documentation for their products. While specific details on the breadth and depth of documentation and support services for each individual product are not extensively detailed in the provided information, both companies are expected to offer comprehensive resources given their industry standing. The Vivid T8 does explicitly mention 3 years of service coverage included.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Reveal LINQ	Vivid T8
Name	Reveal LINQ	Vivid T8
Company	Medtronic	GE HealthCare
Description	Medtronic Reveal LINQ is a tiny, implantable cardiac monitor that continuously records ECG for up to three years, utilizing AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope.	The GE Vivid T8 is a hybrid cardiovascular ultrasound system offering advanced imaging capabilities for cardiac and shared services, designed for reliability and ease of use in diverse clinical settings. It includes AI-based tools for workflow efficiency in its Ultra Edition.
Categories	Cardiology AI, Wearables & Remote Monitoring (RPM)	Cardiology AI
Specialties	Cardiology, Neurology	Cardiology, Radiology
Key Features	World's smallest insertable cardiac monitor (1.2 mL), Continuous ECG monitoring for up to three years, AccuRhythmu2122 AI algorithms for reduced false alerts (AF and pause), Automatic and patient-activated event recording, MRI Conditional (1.5T and 3T) with no post-insertion waiting, Minimally invasive, simplified insertion procedure, Wireless data transmission to CareLinku2122 network via MyCareLinku2122 Patient Monitor, Reveal LINQu2122 Mobile Manager app for clinician device management	Hybrid cardiovascular and shared-service ultrasound capabilities, 19-inch LCD monitor (21.5-inch for Ultra Edition) and 8.4-inch LCD touchscreen (10.1-inch multi-touch for Ultra Edition), 4 active transducer ports, Advanced quantitative tools (e.g., Tissue Velocity Imaging, AutoEF, SmartStress, AFI, Strain/Strain Rate Imaging, AutoIMT), Rugged, durable, and mobile design with extensive stress testing, AI-based tools for workflow efficiency (Vivid T8 Ultra Edition), DICOM and EchoPAC compatibility for image analysis and sharing, Comprehensive cardiovascular scanning applications

Videos

Demos, reviews, and walkthroughs featuring Reveal LINQ and Vivid T8.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate with existing EHR systems and what is the depth of that integration?

The Reveal LINQ system transmits data wirelessly to the CareLinku2122 network, and clinicians can manage the device through the Reveal LINQu2122 Mobile Manager app. The GE Vivid T8, particularly the Ultra Edition, offers DICOM and EchoPAC compatibility for image analysis and sharing, and supports DICOM SR transfers to reporting systems for a fully integrated workflow. Integration with non-GE systems for the Vivid T8 would require careful analysis of application requirements and workflow by the user.

What is the accuracy and sensitivity of the AI algorithms in detecting relevant clinical events for each tool?

The Reveal LINQ utilizes AccuRhythmu2122 AI algorithms to reduce false alerts from AF and pause while preserving sensitivity, with a reported AF detection accuracy rate of 99.7%. The Vivid T8 Ultra Edition includes AI-based tools like AI Auto Measure u2013 2D and AI Auto Measure u2013 Spectrum Recognition, which have shown 99% accuracy and 100% reproducibility in view recognition and 98% accuracy and 100% reproducibility for spectral Doppler measurements.

What is the typical learning curve for a physician or sonographer to become proficient with each device, especially concerning the AI-powered features?

The Reveal LINQ is designed for a minimally invasive, simplified insertion procedure, and its mobile manager app offers guided workflow animations and integrated patient education to streamline device programming and interrogation. The Vivid T8 is described as easy to use with an intuitive user interface and touch-screen capabilities, and its AI-based tools are intended to reduce manual steps and improve workflow efficiency, suggesting a potentially faster ramp-up for staff.

What kind of clinical context or patient profiles are best suited for each tool?

The Reveal LINQ is indicated for patients with clinical syndromes or situations at increased risk of cardiac arrhythmias, and for those experiencing transient symptoms like dizziness, palpitations, syncope, and chest pain that may suggest a cardiac arrhythmia. It is particularly useful for long-term monitoring of infrequent symptoms or for detecting atrial fibrillation in high-risk patients, such as those with cryptogenic stroke. The Vivid T8 is a hybrid cardiovascular ultrasound system offering advanced imaging for cardiac and shared services, suitable for diverse clinical settings and for improving diagnostic confidence in cardiovascular exams.

Are there robust audit-trail features available for tracking device usage, data access, and changes to patient records?

While specific details on audit-trail features for Reveal LINQ are not explicitly provided, the system emphasizes dedicated protection of patient health data and secure data transmission. For the Vivid T8, its DICOM conformance statement indicates support for workflow management services, which typically include tracking of studies and related information, and it offers DICOM encapsulated PDF reports for flexible exam reporting.

Can you provide information on customer references or case studies demonstrating successful multi-site rollouts or significant time-to-value?

Medtronic highlights patient stories and clinical evidence for Reveal LINQ, including its use in diagnosing AF in high-risk patients and its role in earlier diagnosis of asymptomatic arrhythmias. The device has also been successfully implanted in stroke departments, demonstrating adaptability in different clinical settings. GE HealthCare emphasizes that the Vivid T8 Ultra Edition's AI tools can save 7 to 10 minutes per scan, contributing to increased efficiency and potentially faster time-to-value. The Vivid T8 has also undergone rigorous testing for reliability in demanding environments, which is beneficial for multi-site deployments.